News
23andMe Found a Buyer for Our Genetic Data
Digest more
Tarrytown-based Regeneron Pharmaceuticals, Inc. has announced it has been named the successful bidder in the bankruptcy ...
The price tag of this acquisition suggests that the value of genetic data is declining. Back in 2018, the drug company GSK ...
Regeneron, a biotech company, will acquire 23andMe for $256 million and vowed to comply with the genetic testing company's ...
To acquire Personal Genome Service, Total Health and Research Services business lines, and its Biobank and associated assets.
Regeneron Pharmaceuticals is set to acquire substantially all assets of 23andMe for $256 million. The deal is expected to ...
Me, known for its at-home DNA testing kits, is expected to be obtained by its highest bidder following a bankruptcy auction ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results